Gazyva

Gazyva

Basic Prescribing Info
Contents
Obinutuzumab
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FA03 - obinutuzumab ; Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in